Medtronic Analysis: Procedural Growth Versus Guidance Headwinds

Medtronic exceeded profit expectations with strong cardiovascular device sales and procedure volumes. However, the stock declined as the company maintained its annual EPS guidance and highlighted cost pressures, including taxes and tariffs. This episode examines the broader…

Listen